Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nutraceuticals in Psychiatric Disorders: A Systematic Review.
Bozzatello P, Novelli R, Montemagni C, Rocca P, Bellino S. Bozzatello P, et al. Among authors: novelli r. Int J Mol Sci. 2024 Apr 28;25(9):4824. doi: 10.3390/ijms25094824. Int J Mol Sci. 2024. PMID: 38732043 Review.
Combination Drug Therapy for the Management of Chronic Neuropathic Pain.
Boccella S, De Filippis L, Giorgio C, Brandolini L, Jones M, Novelli R, Amorizzo E, Leoni MLG, Terranova G, Maione S, Luongo L, Leone M, Allegretti M, Minnella EM, Aramini A. Boccella S, et al. Among authors: novelli r. Biomolecules. 2023 Dec 16;13(12):1802. doi: 10.3390/biom13121802. Biomolecules. 2023. PMID: 38136672 Free PMC article. Review.
The therapeutic potential of an allosteric non-competitive CXCR1/2 antagonist for diabetic nephropathy.
Grasselli C, Bombelli S, D'Esposito V, Di Tolla MF, L'Imperio V, Rocchio F, Miscione MS, Formisano P, Pagni F, Novelli R, Ruffini PA, Aramini A, Allegretti M, Perego R, De Filippis L. Grasselli C, et al. Among authors: novelli r. Diabetes Metab Res Rev. 2023 Oct;39(7):e3694. doi: 10.1002/dmrr.3694. Epub 2023 Jul 20. Diabetes Metab Res Rev. 2023. PMID: 37470287
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action.
Iaconis D, Caccuri F, Manelfi C, Talarico C, Bugatti A, Filippini F, Zani A, Novelli R, Kuzikov M, Ellinger B, Gribbon P, Riecken K, Esposito F, Corona A, Tramontano E, Beccari AR, Caruso A, Allegretti M. Iaconis D, et al. Among authors: novelli r. Viruses. 2023 May 9;15(5):1128. doi: 10.3390/v15051128. Viruses. 2023. PMID: 37243214 Free PMC article.
Ketoprofen, lysine and gabapentin co-crystal magnifies synergistic efficacy and tolerability of the constituent drugs: Pre-clinical evidences towards an innovative therapeutic approach for neuroinflammatory pain.
Aramini A, Bianchini G, Lillini S, Tomassetti M, Pacchiarotti N, Canestrari D, Cocchiaro P, Novelli R, Dragani MC, Palmerio F, Mattioli S, Bordignon S, d'Angelo M, Castelli V, d'Egidio F, Maione S, Luongo L, Boccella S, Cimini A, Brandolini L, Chierotti MR, Allegretti M. Aramini A, et al. Among authors: novelli r. Biomed Pharmacother. 2023 Jul;163:114845. doi: 10.1016/j.biopha.2023.114845. Epub 2023 May 9. Biomed Pharmacother. 2023. PMID: 37167730 Free article.
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer.
Piro G, Carbone C, Agostini A, Esposito A, De Pizzol M, Novelli R, Allegretti M, Aramini A, Caggiano A, Granitto A, De Sanctis F, Ugel S, Corbo V, Martini M, Lawlor RT, Scarpa A, Tortora G. Piro G, et al. Among authors: novelli r. Br J Cancer. 2023 Jan;128(2):331-341. doi: 10.1038/s41416-022-02028-6. Epub 2022 Nov 16. Br J Cancer. 2023. PMID: 36385556 Free PMC article.
The role of C5a-C5aR1 axis in bone pathophysiology: A mini-review.
Ruocco A, Sirico A, Novelli R, Iannelli S, Van Breda SV, Kyburz D, Hasler P, Aramini A, Amendola PG. Ruocco A, et al. Among authors: novelli r. Front Cell Dev Biol. 2022 Aug 8;10:957800. doi: 10.3389/fcell.2022.957800. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36003145 Free PMC article. Review.
51 results